Company Filing History:
Years Active: 2016
Title: Natalia Lygina: Innovator in Cancer Detection
Introduction
Natalia Lygina is a prominent inventor based in Cary, NC (US). She has made significant contributions to the field of cancer detection through her innovative work on cell binding peptides. Her research focuses on improving diagnostic methods for bladder and thyroid cancers.
Latest Patents
Natalia holds 1 patent for her invention titled "Cell binding peptides for diagnosis and detection." This patent provides cell binding peptides that are specifically designed to bind to urothelial and thyroid follicular cells. The peptides are instrumental in the detection and diagnosis of cancers, including bladder and thyroid cancer. The invention includes a device that captures cells using a support with attached cell binding peptides, which can be utilized for effective cancer diagnosis. Additionally, a kit is provided with instructions for capturing cells, enhancing the diagnostic process for these types of cancer.
Career Highlights
Natalia is currently associated with Affinergy Inc., where she continues to advance her research and development in the field of cancer diagnostics. Her work has the potential to significantly impact the way cancers are detected and diagnosed, leading to better patient outcomes.
Collaborations
Natalia has collaborated with notable colleagues, including William David Culp and Martyn Kerry Darby. These collaborations have further enriched her research and contributed to the development of innovative solutions in cancer detection.
Conclusion
Natalia Lygina's contributions to cancer detection through her innovative cell binding peptides exemplify her commitment to advancing medical technology. Her work not only enhances diagnostic capabilities but also holds promise for improving patient care in oncology.